婴儿体外循环心脏手术中头孢唑林与万古霉素的药代动力学
本研究纳入两个各10例婴儿队列,分别接受万古霉素和头孢唑林,构建群体药代动力学模型并模拟给药方案。结果显示两药均符合二室模型,体外循环不影响浓度-时间曲线。模拟表明万古霉素15 mg·kg于1小时输注、每12小时重复,头孢唑林30 mg·kg于10分钟输注、每4小时重复,可维持血浆浓度分别高于4 μg·mL和16 μg·mL。
要点
- 婴儿体外循环心脏手术预防用万古霉素15 mg·kg(1小时输注)每12小时重复。
- 头孢唑林30 mg·kg(10分钟输注)每4小时重复可维持目标浓度。
- 体外循环对两药药代动力学影响可忽略。
核心结论
- 万古霉素15 mg·kg于1小时输注、每12小时重复,头孢唑林30 mg·kg于10分钟输注、每4小时重复,可维持婴儿心脏手术中血浆浓度高于敏感葡萄球菌的折点。
- 头孢唑林浓度可能对部分革兰阴性菌足够,但非全部。
- 体外循环对药代动力学影响可忽略。
研究设计与样本
- 两个独立婴儿队列,均接受体外循环心脏手术。
- 队列1(N=10)测万古霉素血浆浓度,队列2(N=10)测头孢唑林血浆浓度。
- 为每种药物构建混合效应药代动力学模型,并模拟不同给药方案。
主要发现
- 头孢唑林和万古霉素血浆浓度-时间曲线均符合二室模型。
- 万古霉素V1的显著协变量为体重,头孢唑林V1的显著协变量为年龄。
- 体外循环不影响浓度-时间曲线。
- 模拟显示万古霉素15 mg·kg于1小时输注、每12小时重复,头孢唑林30 mg·kg于10分钟输注、每4小时重复,维持血浆浓度分别高于4 μg·mL和16 μg·mL。
- 上述浓度均高于大多数敏感葡萄球菌的MIC90。
关键数值与推荐
- 万古霉素:15 mg·kg,1小时输注,每12小时重复,维持血浆浓度>4 μg·mL。
- 头孢唑林:30 mg·kg,10分钟输注,每4小时重复,维持血浆浓度>16 μg·mL。
- 目标浓度均高于大多数敏感葡萄球菌的MIC90。
临床怎么用
- 婴儿体外循环心脏手术预防用药可参考万古霉素15 mg·kg(1小时输注)每12小时重复。
- 头孢唑林可参考30 mg·kg(10分钟输注)每4小时重复。
- 体外循环期间无需因药代动力学改变而调整剂量。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Gram-positive bacteria account for nearly three-quarters of all surgical site infections. Antibiotic prophylaxis against these bacteria with cephalosporins or, in select circumstances, with vancomycin is considered standard of care for prevention of surgical site infections. There is little evidence to describe the optimal dosing regimen for surgical site infection prophylaxis in infants undergoing cardiac surgery, and a great deal of institutional variability exists in dosing prophylactic antibiotics. We designed this study to describe an optimal dose regimen for cephalosporin and vancomycin based on pharmacokinetic evidence for infant open-heart surgery on cardiopulmonary bypass. METHODS: Two separate cohorts of infants undergoing cardiac surgery with cardiopulmonary bypass were evaluated. Plasma concentrations of vancomycin (cohort 1, N = 10) and cefazolin (cohort 2, N = 10) were measured, and mixed-effects pharmacokinetic models were constructed for each drug. Simulations of various dosing regimens were performed to describe an appropriate dosing regimen necessary to maintain antibiotic concentrations above the susceptibility cutoff for staphylococci. RESULTS: Both cefazolin and vancomycin plasma concentration versus time profiles were characterized by a 2-compartment model. Subject weight was a significant covariate for V1 for vancomycin. Subject age was a significant covariate for V1 for cefazolin. Cardiopulmonary bypass did not influence concentration versus time profiles. Simulations demonstrated that a 1-hour vancomycin infusion (15 mg·kg), repeated every 12 hours and a 10-minute infusion of cefazolin (30 mg·kg), repeated every 4 hours maintained plasma concentrations above 4 μg·mL and 16 μg·mL, for vancomycin and cefazolin, respectively. Both concentrations are above the minimum inhibitory concentration 90 for most susceptible staphylococci. CONCLUSIONS: Prophylactic treatment of vancomycin 15 mg·kg infused >1 hour with 12-hour redosing and cefazolin 30 mg·kg infused >10 minutes with 4-hour redosing will maintain serum levels of each antibiotic above the susceptibility cut-offs for susceptible staphylococci in infants undergoing cardiac surgery. Cefazolin levels may be adequate for some, but not all, Gram-negative bacteria. The effect of cardiopulmonary bypass on pharmacokinetics is negligible.
引用
- Ingrande J, Gutierrez K, Lemmens HJ, et al. Pharmacokinetics of Cefazolin and Vancomycin in Infants Undergoing Open-Heart Surgery With Cardiopulmonary Bypass. Anesth Analg. 2019. PMID: 30995208. doi:10.1213/ANE.0000000000003876
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。